Skip to content

Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19)

Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19) - COVEN Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04497454
Acronym
COVEN
Enrollment
128
Registered
2020-08-04
Start date
2020-05-08
Completion date
2022-12-01
Last updated
2022-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mechanical Ventilation, Respiratory Distress Syndrome, SARS (Severe Acute Respiratory Syndrome)

Brief summary

This is a prospective, randomized, single-center, open-label controlled trial, designed to compare the efficacy of two ventilation strategies (Low Tidal Volume and positive end-expiratory pressure (PEEP) based on the Acute Respiratory Distress Syndrome (ARDS) Network low PEEP-fraction of inspired oxygen inspired oxygen fraction (FIO2) Table versus Low Driving Pressure and PEEP guided by Electrical Impedance Tomography (EIT) in reducing daily lung injury score in patients with acute respiratory distress syndrome caused by COVID-19. The two strategies incorporate different prioritizations of clinical variables. The PEEP-FIO2 table strategy aims to reduce lung overdistension, even if it requires tolerating worse gas exchange. EIT-guided strategy prioritizes mechanical stress protection, avoiding alveolar overdistension and collapse.

Detailed description

Mechanical ventilatory strategy of the ARDS Network low PEEP-FiO2 table will be followed in the control arm. This strategy consists of at least 12 hours of controlled mechanical ventilation following prespecified PEEP and FiO2 combinations chosen dynamically targeting oxygenation. Tidal volume is set at 4-6 mL/Kg of predicted body weight (PBW) and plateau pressure is kept below 30 centimeters of water (cmH2O). Respiratory rate can be as high as 35 breaths per minute titrated to a potential of hydrogen (pH) 7.30-7.45. As oxygenation improves, patients are transitioned to assisted ventilation and then to pressure support ventilation until they are ready to be liberated from the ventilator. During this phase, no attempt is made to control plateau pressures or tidal volumes. In the intervention arm, minimizing tidal lung strain by keeping driving pressure below 16 cmH2O throughout the mechanical ventilation period will be targeted. The controlled phase will last at least 48 hours. PEEP will be selected according to a PEEP titration maneuver with EIT at the start of the intervention. This PEEP level will be kept until extubation. Respiratory rate can be as high as 50 breaths per minute targeting a pH of 7.15-7.45.

Interventions

OTHEREIT-Group

A mechanical ventilation strategy with the main goal to maintain DP \< 16 cmH2O

OTHERARDSNet

Low PEEP-FiO2 table ARDS Network ventilation protocol

Sponsors

InCor Heart Institute
CollaboratorOTHER
University of Sao Paulo General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Prospective, randomized, single-center, open-label, superiority, controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients under mechanical ventilation with ARDS (Berlin definition) caused by SARS-COV2 infection: * ARDS diagnosis in less than 24 hours * Respiratory System Compliance of 0.6 mL/cmH2O/Kg of PBW

Exclusion criteria

* Age \< 18 years * Active bronchopleural fistula * History of chronic and disabling respirator disease, requiring home oxygen treatment * Chronic pulmonary arterial hypertension (pulmonary artery systolic pressure \> 40 mmHg) * Huge intrathoracic tumoral mass * Electrical impedance tomography monitoring contraindications (as thoracic wounds or burns, electronic implantable devices) * Hemodynamic instability (systolic pressure \< 80 mmHg or mean arterial pressure \< 60 mmHg, despite vasopressor drugs; and/or heart rate \< 55bpm) - this patient may be included after recovered from hemodynamic instability * Not drained pneumothorax or subcutaneous emphysema or bronchopleural fistula * Patients at risk of intracranial hypertension development or post Cardiopulmonary resuscitation (first 72 hours) * Pregnancy * Impossibility of monitoring with EIT * Not committed to full support or life expectation \< 24 hours * Legal responsible or clinical team refusal to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Average daily Modified Lung injury score until day 28dailyThis score originally ranges from 0 to 4 points based on the average of 4 parameters (PaO2/FiO2, chest X-Ray, PEEP level, and Respiratory compliance). In the modified version, if the patient dies, he or she automatically receives a score of 5 irrespective of the other four parameters. If the patient is extubated, the score is automatically zero. We also substituted FiO2 for PEEP guaranteeing equivalence of the score when either the low or high PEEP-FiO2 table is applied.

Secondary

MeasureTime frameDescription
High oxygen dependence free days until day 2828 daysNumber of days with less than or equal to 1 Liter/min of oxygen supplementation until day 28
Mechanical ventilation free days until day 2828 daysNumber of days free of mechanical ventilation assistance after protocol inclusion and before day 28
Incidence of shock or barotrauma28 daysOccurrence of shock (persistent hypotension despite rescue measures) and incidence of barotrauma
Incidence of acute renal failure requiring renal replacement therapy28 daysOccurrence of acute renal failure that justifies renal replacement therapy
28-day mortality28 daysPercentage of patients who died in each arm up to 28 days

Countries

Brazil

Contacts

Primary ContactEduardo LV Costa, PhD
eduardoleitecosta@gmail.com+551130617361
Backup ContactMaria AM Nakamura, PhD
mamiyukinakamura@gmail.com+551130617151

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026